IL22 and arthritic joint disease: Results in animal models are also debated, whereas IL-22−/− mice show reduced incidence of CIA (57), recombinant IL-22 administration prior to arthritis onset reduces disease severity (58), suggesting a dual role for IL-22 during RA development (59).